Curative Biotechnology, Inc. announced two additions to Scientific and Clinical Advisory Board. Both are important thought leaders in their respective fields and have joined Scientific and Clinical Advisory Board to help guide programs through pre-clinical and clinical development. Kapil Bharti, Ph.D. from the National Eye Institute (NEI) at the National Institutes of Health (NIH) has joined Scientific and Clinical Advisory Board. Dr. Bharti is the lead inventor on the U.S. and Worldwide patent applications licensed exclusively to Curative Biotech to repurpose Metformin into an eye drop to treat degenerative eye diseases like macular degeneration, diabetic retinopathy, Stargardt's disease, and others.